Actively Recruiting
Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care
Led by Birmingham Women's NHS Foundation Trust · Updated on 2025-08-15
50
Participants Needed
1
Research Sites
42 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The overall aim of this research proposal is to explore the feasibility and acceptability of home antenatal maternal-fetal monitoring technology within a high-risk pregnancy group. The investigators hypothesise that home monitoring is feasible and acceptable to both pregnant women and HCPs. 50 women from a single site will be recruited to use a home cardiotocography (CTG) device alongside routine antenatal care. Participants will use this device once a week, for an hour at a time, for up to 6 weeks or until delivery. The primary outcome is 20 minutes of continuous monitoring. Additional outcomes assess acceptability, adherence and safety.
CONDITIONS
Official Title
Remote Cardiotocography Telemonitoring Within High-risk Pregnancy Care
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged ≥18 years
- Gestational age 32+0 weeks onwards.
- Singleton pregnancy.
- Able to speak English
- Receiving antenatal care which includes routine antenatal fetal monitoring for one of the 6 index conditions (hypertensive disease in pregnancy, reduced fetal growth (small for gestational age and fetal growth restriction) obstetric cholestasis, PPROM, previous history of stillbirth and recurrent reduced fetal movements )
- Able to give written informed consent.
- Willing to attend hospital immediately in the event of an unexpected finding whilst using the home devices.
You will not qualify if you...
- Multiple pregnancy.
- Fetal abnormalities or a non-viable fetus.
- Body mass index (BMI) ≥35
- Women with internal cardiac devices such as pacemaker and implantable cardioverter defibrillator.
- History of allergic reaction to skin adhesives and/or latex.
- Acute or chronic skin lesions and wounds in areas in contact with the device.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Birmingham Women's and Children's NHS Foundation Trust
Birmingham, United Kingdom, B152TG
Actively Recruiting
Research Team
J
Jack Hamer, MBChB
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here